MRI Masterclass for the Diagnosis and Management of Prostate Cancer

  • 18 hours
  • 2 days
  • 06 September 2019


Learn everything you need to know about prostate MRI for the diagnosis and management of patients with prostate cancer on this two-day course for urologists (trainees and consultants).

The prostate cancer-management pathway is moving towards image-guided diagnosis and treatment. This course will provide interactive teaching from a world-renowned faculty in prostate MRI interpretation.

It will equip urologists to be able to use MRI in the management of patients with prostate cancer and run an image-guided service.

Places are limited to 24 people. You'll gain 12 CPD points.

This short course is run by staff at UCL and UCLH (University College London Hospital). It's accredited by the British Association of Urological Surgeons.

Course content

The course will cover the following:

  • The importance of prostate MRI to the urologist
  • Recognising prostate anatomy on MRI
  • Identifying areas suspicious for prostate cancer on multi-parametric MRI
  • How to use MRI to help guide management decisions in prostate cancer patients
  • Contouring the prostate on MRI prior to MRI-targeted biopsy and treatments
  • Using MRI imaging to guide prostate biopsy

Who this course is for

You'll need to be a urological consultant or trainee with an interest in prostate cancer.

Course structure and teaching

The course runs over two days, with the following learning format:

  • Hands-on MRI interpretation workshop with expert faculty using real prostate MRIs
  • You'll be given a Mac with OSIRIX software for viewing MRI scans and will have significant time to interpret new scans with individual feedback on performance
  • Hands-on demonstration of image-fusion software in MRI-targeted prostate biopsy
  • Lectures and case-based discussions to demonstrate the role of MRI in the diagnosis and treatment of men with prostate cancer

CPD accreditation and certificates

You'll be assessed at baseline and at the end of the course in the interpretation of prostate MRI images to demonstrate what you've learnt. You'll receive a breakdown of your performance by email following the course.

You'll receive a certificate of attendance.

CPD points from the British Association of Urological Surgeons (BAUS) have been applied for. Last year this course was worth 12 points. 

Learning outcomes

By the end of the course you should be able to:

  • understand the importance of multi-parametric MRI interpretation for the practicing urologist
  • recognise prostate anatomy on multi-parametric MRI
  • identify areas suspicious for prostate cancer on multi-parametric MRI
  • understand the limitations of prostate multi-parametric MRI
  • recognise good and bad multi-parametric MRI scan quality and understand how to optimise this
  • use multi-parametric MRI to help guide management decisions in prostate cancer patients (specifically, for the planning of robotic prostatectomy and focal therapy)
  • contour the prostate on MRI prior to MRI-targeted biopsy and treatments
  • use multi-parametric MRI to guide prostate biopsy

How you and your employer will benefit

UCL and UCLH are at the international forefront of prostate MRI research and use in clinical practice. Over 1000 MRI scans are performed at UCLH every year. UCL researchers have played a key role in the development and evaluation of this technology in clinical practice. The faculty comprise some of these key researchers and clinicians.

You'll also:

  • benefit from networking opportunities with faculty
  • have the opportunity to get involved in research in MRI-targeted biopsy
  • be able to launch your own image-guided diagnostic services at your own trusts
Course team

Dr Clare Allen

Clare qualified from Oxford University and is Consultant Radiologist at UCL with an academic interest in uro-oncology, in particular prostate MR-imaging. She has a well-developed clinical practice in dynamic contrast-enhanced MR in the prostate and is leading a team of medical physicists in further defining the role of multi-sequence MRI in diagnostic utility of prostate cancer.

Veeru Kasivisvanathan

Veeru is an NIHR Doctoral Fellow and Specialist Registrar in Urology. He's completing a PhD evaluating the role of MRI-targeted biopsies in the diagnosis of prostate cancer and is coordinating an international multi-centre randomised controlled trial, PRECISION (NCT02380027), as part of this. He's part of the team that runs the diagnostic MRI-targeted biopsy service at UCLH and is responsible for the multi-disciplinary team management of these patients.

Joseph Norris

Joseph is a Specialist Registrar in Urology in the London Deanery. He’s also the MRC Doctoral Fellow at UCL, undertaking a PhD examining detection of prostate cancer by mpMRI. Joseph has an active clinical and academic interest in the diagnosis and tissue-sparing treatment of localised prostate cancer.

Dr Alex Kirkham

Alex is Consultant Radiologist at UCLH, specialising in urological radiology. He has both a clinical and a research interest in prostate cancer imaging, in particular MRI for the detection of tumour and the assessment of ablative therapies.

Professor Caroline Moore

Caroline is a Consultant Urological Surgeon at University College Hospital, and Professor of Urology in the Department of Targeted Intervention, UCL. She leads a significant research programme at UCL, focusing on MRI-targeted prostate biopsy, active surveillance and focal therapy for prostate cancer (such as PICTURE & SmartTarget) for which she’s also involved in numerous international collaborations.

Dr Francesco Giganti

Francesco is a clinical research fellow in the Department of Targeted Intervention, UCL and the Department of Radiology, UCLH. He’s an expert in teaching prostate MRI for urologists, and part of the team commissioned by EAU to deliver Europe-wide training courses.

Clement Orczyk

Clement is an Associate Professor of Urology at UCL and currently works at the Department of Urology, UCL and UCLH, where he runs a focal therapy (HIFU & cryotherapy) clinic. His research focuses on management of prostate cancer, diagnosis and focal therapy of prostate cancer.

Course information last modified: 21 Jun 2019, 13:46